| P50 | author | Gin Malhi | Q89872646 |
| P2093 | author name string | K N Roy Chengappa | |
| | Samuel Gershon | |
| | Seyyed N Ghaemi | |
| P2860 | cites work | Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis | Q28303010 |
| | Comparison of manic and depressive symptoms between children and adolescents with bipolar spectrum disorders | Q33686094 |
| | Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. | Q33814201 |
| | Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial | Q34616063 |
| | Validity and utility of bipolar spectrum models | Q37058587 |
| | Lithium specificity in bipolar illness: a classic agent for the classic disorder | Q37524489 |
| | Is lithium in a class of its own? A brief profile of its clinical use. | Q37650273 |
| | Hypomania: hype or mania? | Q42697963 |
| | A novel augmentation strategy for treating resistant major depression | Q43514882 |
| | From chlorpromazine to olanzapine: a brief history of antipsychotics | Q46434604 |
| | What is a mood stabilizer? | Q50916088 |
| P433 | issue | 7-8 | |
| P304 | page(s) | 583-586 | |
| P577 | publication date | 2011-11-01 | |
| P1433 | published in | Bipolar Disorders | Q15716681 |
| P1476 | title | Atypical mood stabilizers: a new role for neuroleptics? | |
| P478 | volume | 13 | |